Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan;6(1):15-20.
doi: 10.3892/br.2016.807. Epub 2016 Nov 10.

Role of inflammatory cytokines in depression: Focus on interleukin-1β

Rai Khalid Farooq  1 , Kashif Asghar  2 , Shahzina Kanwal  3 , Ali Zulqernain  4
Affiliations

Role of inflammatory cytokines in depression: Focus on interleukin-1β

Rai Khalid Farooq et al. Biomed Rep. 2017 Jan.

Abstract

According to the World Health Organization, major depression will become the leading cause of disability worldwide by the year 2030. Despite extensive research into the mechanisms underlying this disease, the rate, prevalence and disease burden has been on the rise, particularly in the industrialized world. Epidemiological studies have shown biological and biochemical differences in disease characteristics and treatment responses in different age groups. Notable differences have been observed in the clinical presentation, co-prevalence with other diseases, interaction with the immune system and even in the outcome. Thus, there is an increased interest in characterizing these differences, particularly in terms of contribution of different factors, including age, cytokines and immunotherapy. Research into the possible mechanisms of these interactions may reveal novel opportunities for future pharmacotherapy. The aim of the present review is to document recent literature regarding the impact of inflammatory mechanisms on the pathophysiology of the depressive disorder.

Keywords: cytokines; depression; interleukin-1β; neuroinflammation.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442. doi: 10.1371/journal.pmed.0030442. - DOI - PMC - PubMed
    1. Seligman ME, Csikszentmihalyi M. Positive psychology: an introduction. Springer; Netherlands, Dordrecht: 2014. pp. 279–298.
    1. Murphy DL, Cohen RM, Siever LJ, Roy B, Karoum F, Wyatt RJ, Garrick NA, Linnoila M. Clinical and laboratory studies with selective monoamine-oxidase-inhibiting drugs. Implications for hypothesized neurotransmitter changes associated with depression and antidepressant drug effects. Mod Probl Pharmacopsychiatry. 1983;19:287–303. doi: 10.1159/000407526. - DOI - PubMed
    1. Ader R, Cohen N. High time for psychoimmunology. Nature. 1985;315:103–104. doi: 10.1038/315103b0. - DOI - PubMed
    1. Maes M. Evidence for an immune response in major depression: A review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 1995;19:11–38. doi: 10.1016/0278-5846(94)00101-M. - DOI - PubMed